{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:32:48Z","timestamp":1772109168132,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"vor","delay-in-days":5179,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1046\/j.1469-0691.2000.00152.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T12:20:10Z","timestamp":1047385210000},"page":"608-612","source":"Crossref","is-referenced-by-count":12,"title":["In vitro activity of quinupristin\/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci"],"prefix":"10.1016","volume":"6","author":[{"given":"R.","family":"Auckenthaler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Courvalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"F\u00e9ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2000.00152.x_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/30.suppl_A.1","article-title":"Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds","volume":"30","author":"Barri\u00e8re","year":"1992","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/39.suppl_1.15","article-title":"In-vitro and in-vivo antibacterial activity of quinupristin\/dalfopristin","volume":"39","author":"Bouanchaud","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/39.suppl_1.59","article-title":"A review of the in-vitro activity of quinupristin\/dalfopristin against intracellular pathogens and mycoplasmas","volume":"39","author":"B\u00e9b\u00e9ar","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/30.suppl_A.95","article-title":"In-vitro and in-vivo synergistic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500","volume":"30","author":"Bouanchaud","year":"1992","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/30.suppl_A.83","article-title":"The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination","volume":"30","author":"Neu","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib7","series-title":"Manual of clinical microbiology","first-page":"264","author":"Kloos","year":"1995"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib8","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved standard M7-A4","year":"1999"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/39.suppl_1.81","article-title":"Development of provisional disc diffusion breakpoints for testing quinupristin\/dalfopristin","volume":"39","author":"Tenover","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJM199805073381909","article-title":"Multidrug resistance\u2014a sign of the times","volume":"338","author":"Levy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.suppl_1.1","article-title":"Antibiotic resistance in Gram-positive bacteria: epidemiological aspects","volume":"44","author":"Witte","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib12","first-page":"813","article-title":"Update: Staphylococcus aureus with reduced susceptibility to vancomycin\u2014United States, 1997","volume":"46","year":"1997","journal-title":"MMWR"},{"issue":"5A","key":"10.1046\/j.1469-0691.2000.00152.x_bib13","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(98)00153-3","article-title":"Evaluation of the in vitro activity of quinupristin\/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates","volume":"104","author":"Dowziky","year":"1998","journal-title":"Am J Med"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib14","series-title":"Programme and Abstracts of the Twentieth International Congress of Chemotherapy (ICC), Sydney, Australia","first-page":"44","article-title":"Efficacy of quinupristin\/dalfopristin (Synercid, RP 59500) in the treatment of patients with positive blood cultures in global phase III studies [abstract 2317]","author":"Talbot","year":"1997"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/30.suppl_A.59","article-title":"In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies","volume":"30","author":"Hoban","year":"1992","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1046\/j.1469-0691.2000.00152.x_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/39.suppl_1.7","article-title":"Inhibition of protein synthesis by streptogramins and related antibiotics","volume":"39","author":"Cocito","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/13543784.7.4.591","article-title":"Streptogramin antibiotics: update on their mechanism of action","volume":"7","author":"Beyer","year":"1998","journal-title":"Expert Opin Invest Drugs"},{"issue":"2","key":"10.1046\/j.1469-0691.2000.00152.x_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/AAC.39.2.400","article-title":"Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 in experimental endocarditis due to Staphylococcus aureus","volume":"32","author":"Fantin","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2000.00152.x_bib19","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.42.7.1794","article-title":"Characterization of a staphylococcal plasmid related to pUB10 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics","volume":"42\/7","author":"Allignet","year":"1998","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15600064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15600064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T07:46:31Z","timestamp":1580975191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15600064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S1198743X15600064"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2000.00152.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}